Martin Shkreli, the pharmaceutical entrepreneur facing U.S. charges of securities fraud, has said he had been the target of legal authorities for his much-criticized drug-price hikes and his over-the-top public persona, the Wall Street Journal reported.
from CBC | Health News http://ift.tt/1OGcFOP
Aucun commentaire:
Enregistrer un commentaire